Found: 4
Select item for more details and to access through your institution.
nab‐Paclitaxel plus gemcitabine in metastatic pancreatic adenocarcinoma: Australian subset analyses of the phase III MPACT trial.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2018, v. 14, n. 5, p. e325, doi. 10.1111/ajco.12999
- By:
- Publication type:
- Article
Enhanced photoinduced antibacterial activity of a BODIPY photosensitizer in the presence of polyamidoamines.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Prognostic Factors ofSurvival in a Randomized Phase III Trial (MPACT) of Weekly nab-Paclitaxel Plus Gemcitabine Versus Gemcitabine Alone in Patients With Metastatic Pancreatic Cancer.
- Published in:
- Oncologist, 2015, v. 20, n. 2, p. 143, doi. 10.1634/theoncologist.2014-0394
- By:
- Publication type:
- Article
nab-Paclitaxel plus gemcitabine for metastatic pancreatic cancer: a subgroup analysis of the Western European cohort of the MPAC T trial.
- Published in:
- OncoTargets & Therapy, 2017, v. 10, p. 591, doi. 10.2147/OTT.S124097
- By:
- Publication type:
- Article